- Home
- Publications
- Publication Search
- Publication Details
Title
PARP3 comes to light as a prime target in cancer therapy
Authors
Keywords
-
Journal
CELL CYCLE
Volume -, Issue -, Pages 1-7
Publisher
Informa UK Limited
Online
2019-05-17
DOI
10.1080/15384101.2019.1617454
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Exploring and comparing adverse events between PARP inhibitors
- (2019) Christopher J LaFargue et al. LANCET ONCOLOGY
- Emerging roles of eraser enzymes in the dynamic control of protein ADP-ribosylation
- (2019) Julia O’Sullivan et al. Nature Communications
- Characterization of DNA ADP-ribosyltransferase activities of PARP2 and PARP3: new insights into DNA ADP-ribosylation
- (2018) Gabriella Zarkovic et al. NUCLEIC ACIDS RESEARCH
- Dna is a New Target of Parp3
- (2018) E. A. Belousova et al. Scientific Reports
- PARP3 inhibitors ME0328 and olaparib potentiate vinorelbine sensitization in breast cancer cell lines
- (2018) Bahram Sharif-Askari et al. BREAST CANCER RESEARCH AND TREATMENT
- Parp3 promotes long-range end joining in murine cells
- (2018) Jacob V. Layer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PARP3, a new therapeutic target to alter Rictor/mTORC2 signaling and tumor progression in BRCA1-associated cancers
- (2018) Carole Beck et al. CELL DEATH AND DIFFERENTIATION
- New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
- (2018) Anushka Dongre et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Reversible mono-ADP-ribosylation of DNA breaks
- (2017) Deeksha Munnur et al. FEBS Journal
- ADP-ribosylation of DNA moving into focus
- (2017) Christian Dölle et al. FEBS Journal
- PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes
- (2017) Rebecca Gupte et al. GENES & DEVELOPMENT
- PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA
- (2017) Tovah A. Day et al. Nature Communications
- PARP3 is a sensor of nicked nucleosomes and monoribosylates histone H2BGlu2
- (2016) Gabrielle J. Grundy et al. Nature Communications
- PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis
- (2016) Olga Karicheva et al. Oncotarget
- Rictor Undergoes Glycogen Synthase Kinase 3 (GSK3)-dependent, FBXW7-mediated Ubiquitination and Proteasomal Degradation
- (2015) Junghui Koo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PARP3 interacts with FoxM1 to confer glioblastoma cell radioresistance
- (2015) Jun-Jie Quan et al. TUMOR BIOLOGY
- Type II transglutaminase stimulates epidermal cancer stem cell epithelial-mesenchymal transition
- (2015) Matthew L. Fisher et al. Oncotarget
- Parp3 Negatively Regulates Immunoglobulin Class Switch Recombination
- (2015) Isabelle Robert et al. PLoS Genetics
- TGFβ1 Protects Cells from γ-IR by Enhancing the Activity of the NHEJ Repair Pathway
- (2014) Mi-Ra Kim et al. MOLECULAR CANCER RESEARCH
- mTOR regulate EMT through RhoA and Rac1 pathway in prostate cancer
- (2014) XianGuo Chen et al. MOLECULAR CARCINOGENESIS
- Nox4-Mediated Cell Signaling Regulates Differentiation and Survival of Neural Crest Stem Cells
- (2014) Ji-Eun Lee et al. MOLECULES AND CELLS
- PARP3 affects the relative contribution of homologous recombination and nonhomologous end-joining pathways
- (2014) Carole Beck et al. NUCLEIC ACIDS RESEARCH
- PARP-2 and PARP-3 are selectively activated by 5′ phosphorylated DNA breaks through an allosteric regulatory mechanism shared with PARP-1
- (2014) Marie-France Langelier et al. NUCLEIC ACIDS RESEARCH
- PARP Inhibitor with Selectivity Toward ADP-Ribosyltransferase ARTD3/PARP3
- (2013) Anders E. G. Lindgren et al. ACS Chemical Biology
- The PARP3- and ATM-dependent phosphorylation of APLF facilitates DNA double-strand break repair
- (2013) Amanda L. Fenton et al. NUCLEIC ACIDS RESEARCH
- mTOR complex 2 signaling and functions
- (2011) Won Jun Oh et al. CELL CYCLE
- Role of tissue transglutaminase 2 in the acquisition of a mesenchymal-like phenotype in highly invasive A431 tumor cells
- (2011) Chun-Yu Lin et al. Molecular Cancer
- PARP-3 and APLF Function Together to Accelerate Nonhomologous End-Joining
- (2011) Stuart L. Rulten et al. MOLECULAR CELL
- Tissue transglutaminase links TGF-β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer
- (2011) L Cao et al. ONCOGENE
- A Key Role for Poly(ADP-Ribose) Polymerase 3 in Ectodermal Specification and Neural Crest Development
- (2011) Michèle Rouleau et al. PLoS One
- Poly(ADP-ribose) polymerase 3 (PARP3), a newcomer in cellular response to DNA damage and mitotic progression
- (2011) C. Boehler et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PARP-3 Is a Mono-ADP-ribosylase That Activates PARP-1 in the Absence of DNA
- (2010) Olga Loseva et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tissue Transglutaminase Promotes Drug Resistance and Invasion by Inducing Mesenchymal Transition in Mammary Epithelial Cells
- (2010) Anupam Kumar et al. PLoS One
- Epithelial-to-Mesenchymal Transition and Ovarian Tumor Progression Induced by Tissue Transglutaminase
- (2009) M. Shao et al. CANCER RESEARCH
- mTOR signaling at a glance
- (2009) M. Laplante et al. JOURNAL OF CELL SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search